In 2014, the narcotic overdose treatment Naloxone cost $690. Today, the same drug sells for $4,500.

GRAND RAPIDS — Drug developer Tetra Discovery Partners Inc. plans to launch a clinical trial later this spring on a potential treatment for an autism spectrum disorder.

The amount of venture capital invested in biotech and health care startups based in Michigan nearly doubled in 2017.

GRAND RAPIDS — A Colorado company wants Spectrum Health to quit using the MedNow moniker for its telemedicine service.

GRAND RAPIDS — An on-demand home health service Spectrum Health debuted a month ago aims to aid not only patients but also the people who care for them.

A Holland-based venture capital firm closed last week on $7.2 million of the $10 million it seeks to raise to invest in health care startups

GRAND RAPIDS — The foundation supporting Mercy Health Saint Mary’s made staffing changes in preparation for a major capital campaign that could launch this summer.

The largest organization representing Michigan doctors is opposing legislation that would create a new way for physicians in the state to obtain medical licenses in other states to practice telemedicine.

GRAND RAPIDS — Nearly four years after forming a research center, Mary Free Bed Rehabilitation Hospital wants to focus more on exploring and developing potential new therapies to treat patients.

Transparency in health care in Michigan took a step forward with the launch of yet another online database for patients across the state to look up hospital data.

Whether a coalition of large health systems that plans to get into the generic drug business can actually do something about shortages or escalating prices remains to be seen.

GRAND RAPIDS — Mercy Health’s new primary care medical practice on Grand Rapids’ west side resulted from what Ben Look calls a lot of dissatisfaction.

KALAMAZOO — Armune BioScience Inc.’s sale to a Wisconsin company provides another exit for investors that generates returns they can use in future deals for life sciences startups in Michigan.

KALAMAZOO — Armune BioScience Inc.’s sale to Madison, Wis.-based Exact Sciences Corp. reinforces the reality that some West Michigan-based life sciences firms will have to move out of the region to grow.

The deal to buy a majority stake in Muskegon-based Shoreline Vision serves as the largest transaction yet for Great Lakes Management Services Organization.